Risk of Death in Patients Hospitalized for COVID-19 vs Seasonal Influenza in Fall-Winter 2022-2023
- PMID: 37022720
- PMCID: PMC10080400
- DOI: 10.1001/jama.2023.5348
Risk of Death in Patients Hospitalized for COVID-19 vs Seasonal Influenza in Fall-Winter 2022-2023
Plain language summary
This study uses data from the US Department of Veterans Affairs to assess whether SARS-CoV-2 remains associated with higher risk of death compared with seasonal influenza in fall-winter 2022-2023.
Conflict of interest statement
Figures
Similar articles
-
Mortality in Patients Hospitalized for COVID-19 vs Influenza in Fall-Winter 2023-2024.JAMA. 2024 Jun 11;331(22):1963-1965. doi: 10.1001/jama.2024.7395. JAMA. 2024. PMID: 38748411 Free PMC article.
-
Comparative evaluation of clinical manifestations and risk of death in patients admitted to hospital with covid-19 and seasonal influenza: cohort study.BMJ. 2020 Dec 15;371:m4677. doi: 10.1136/bmj.m4677. BMJ. 2020. PMID: 33323357 Free PMC article. No abstract available.
-
The Annual Burden of Seasonal Influenza in the US Veterans Affairs Population.PLoS One. 2017 Jan 3;12(1):e0169344. doi: 10.1371/journal.pone.0169344. eCollection 2017. PLoS One. 2017. PMID: 28046080 Free PMC article.
-
COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries.Rheumatology (Oxford). 2021 Oct 9;60(SI):SI37-SI50. doi: 10.1093/rheumatology/keab250. Rheumatology (Oxford). 2021. PMID: 33725121 Free PMC article.
-
Seasonal Influenza (Flu).Nurs Clin North Am. 2019 Jun;54(2):227-243. doi: 10.1016/j.cnur.2019.02.009. Nurs Clin North Am. 2019. PMID: 31027663 Review.
Cited by
-
Comparative Epidemiological and Clinical Outcomes on COVID-19 and Seasonal Influenza Hospitalized Patients during 2023.Infect Dis Rep. 2024 Aug 23;16(5):783-793. doi: 10.3390/idr16050060. Infect Dis Rep. 2024. PMID: 39311201 Free PMC article.
-
In-hospital mortality, comorbidities, and costs of one million mechanically ventilated patients in Germany: a nationwide observational study before, during, and after the COVID-19 pandemic.Lancet Reg Health Eur. 2024 Jun 7;42:100954. doi: 10.1016/j.lanepe.2024.100954. eCollection 2024 Jul. Lancet Reg Health Eur. 2024. PMID: 39070745 Free PMC article.
-
A Natural Bioactive Peptide from Pinctada fucata Pearls Can Be Used as a Potential Inhibitor of the Interaction between SARS-CoV-2 and ACE2 against COVID-19.Int J Mol Sci. 2024 Jul 19;25(14):7902. doi: 10.3390/ijms25147902. Int J Mol Sci. 2024. PMID: 39063143 Free PMC article.
-
Kinetics of pro- and anti-inflammatory spike-specific cellular immune responses in long-term care facility residents after COVID-19 mRNA primary and booster vaccination: a prospective longitudinal study in Japan.Immun Ageing. 2024 Jun 22;21(1):41. doi: 10.1186/s12979-024-00444-1. Immun Ageing. 2024. PMID: 38909235 Free PMC article.
-
Intracellular Pathogens: Infection, Immunity, and Intervention.Methods Mol Biol. 2024;2813:1-17. doi: 10.1007/978-1-0716-3890-3_1. Methods Mol Biol. 2024. PMID: 38888767 Review.
References
-
- Laboratory-confirmed COVID-19–associated hospitalizations. Centers for Disease Control and Prevention . Accessed March 7, 2023. https://gis.cdc.gov/grasp/covidnet/covid19_3.html
-
- Influenza Hospitalization Surveillance Network (FluSurv-NET). Accessed March 7, 2023. Centers for Disease Control and Prevention . https://www.cdc.gov/flu/weekly/influenza-hospitalization-surveillance.htm
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
